Document Detail


A matched group study of triple negative versus HER-2 positive (irrespective of hormonal status) breast cancer: two subtypes with high-risk features and poor outcome.
MedLine Citation:
PMID:  22276028     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
INTRODUCTION: Genetic profile studies of breast cancer identified a number of biologically different subtypes. These genetic subtypes are often surrogated by oestrogen receptors (ERs), progesterone receptors (PR) and HER2 status as measured by immunohistochemistry (IHC). Triple negative (TN) subtype is recognized to have high-risk features and poor outcome. Over-expression of the HER2 is also recognized as poor outcome marker. The characteristics and outcome of HER2 positive tumours (irrespective of hormonal status) (HER2 HR+/-) identified by IHC have not addressed in the era of surrogate genetic subtyping. Therefore, we retrospectively compared the risk features and clinical outcome of patients with TN against these with HER2 HR+/- tumours.
PATIENTS AND METHODS: Forty patients with HER2 HR+/- tumours were matched for age and stage to 40 patients with TN tumours. Clinical and pathological data were collected retrospectively. All patients were managed in a single institution.
RESULTS: Tumour grade and stage and rate of pathologically involved lymph nodes were similar in both groups. There was a trend of more lymphovascular invasion in HER2 HR+/- than TN patients (40% vs. 27.5%. p=0.07). Relapse and death rates were not statistically different (p=0.469 and p=1.0, respectively). Median relapse free survival was 38 months for TN and not reached for HER2 HR+/- patients (Log rank; p=0.757). Median overall survival was not reached in both groups. Multivariate analysis did not identify TN or HER2 HR+/- status to have any differential impact on RFS.
CONCLUSION: HER2 HR+/- tumours exhibit high risk, presenting features and relatively poor clinical outcome possibly not very different from the increasingly recognized TN tumour.
Authors:
J M Zekri; E Ibrahim; B Ben Sadiq; Am Al-Gahmi; Aa Zeeneldin; Tr Elkhodary; He Gaballa; Ee Fawzy; Me Elsayed; Y Bahadur; S Awadalla; Ms Alzahran
Related Documents :
22431238 - Oral and oropharyngeal squamous cell carcinoma in young patients: the netherlands cance...
2249188 - Conservative surgery and radiation therapy for soft tissue sarcoma of the wrist, hand, ...
22734678 - The quality of life after a total gastrectomy with extended lymphadenectomy and omega t...
22785208 - Stromal galectin-1 expression is associated with long-term survival in resectable pancr...
16769988 - Does granulocyte colony-stimulating factor worsen anemia in early breast cancer patient...
24577128 - Lower ras expression as an independent predictor of patient outcomes in lung cancer tre...
Publication Detail:
Type:  Journal Article     Date:  2010-08-27
Journal Detail:
Title:  Ecancermedicalscience     Volume:  4     ISSN:  1754-6605     ISO Abbreviation:  Ecancermedicalscience     Publication Date:  2010  
Date Detail:
Created Date:  2012-01-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101392236     Medline TA:  Ecancermedicalscience     Country:  England    
Other Details:
Languages:  eng     Pagination:  167     Citation Subset:  -    
Affiliation:
Department of Oncology.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  IART (Intra-Operative Avidination for Radionuclide Therapy) for accelerated radiotherapy in breast c...
Next Document:  Metachronous bladder metastases from renal cell carcinoma: a case report and review of the literatur...